228 related articles for article (PubMed ID: 33799504)
1. Garcinol-A Natural Histone Acetyltransferase Inhibitor and New Anti-Cancer Epigenetic Drug.
Kopytko P; Piotrowska K; Janisiak J; Tarnowski M
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33799504
[TBL] [Abstract][Full Text] [Related]
2. Polyisoprenylated benzophenone, garcinol, a natural histone acetyltransferase inhibitor, represses chromatin transcription and alters global gene expression.
Balasubramanyam K; Altaf M; Varier RA; Swaminathan V; Ravindran A; Sadhale PP; Kundu TK
J Biol Chem; 2004 Aug; 279(32):33716-26. PubMed ID: 15155757
[TBL] [Abstract][Full Text] [Related]
3. Garcinol inhibits esophageal cancer metastasis by suppressing the p300 and TGF-β1 signaling pathways.
Wang J; Wu M; Zheng D; Zhang H; Lv Y; Zhang L; Tan HS; Zhou H; Lao YZ; Xu HX
Acta Pharmacol Sin; 2020 Jan; 41(1):82-92. PubMed ID: 31371781
[TBL] [Abstract][Full Text] [Related]
4. Chemical and Biological Aspects of Garcinol and Isogarcinol: Recent Developments.
Schobert R; Biersack B
Chem Biodivers; 2019 Sep; 16(9):e1900366. PubMed ID: 31386266
[TBL] [Abstract][Full Text] [Related]
5. Garcinol, an acetyltransferase inhibitor, suppresses proliferation of breast cancer cell line MCF-7 promoted by 17β-estradiol.
Ye X; Yuan L; Zhang L; Zhao J; Zhang CM; Deng HY
Asian Pac J Cancer Prev; 2014; 15(12):5001-7. PubMed ID: 24998578
[TBL] [Abstract][Full Text] [Related]
6. The C8 side chain is one of the key functional group of Garcinol for its anti-cancer effects.
Zhou XY; Cao J; Han CM; Li SW; Zhang C; Du YD; Zhou QQ; Zhang XY; Chen X
Bioorg Chem; 2017 Apr; 71():74-80. PubMed ID: 28169002
[TBL] [Abstract][Full Text] [Related]
7. Garcinol, a histone acetyltransferase inhibitor, radiosensitizes cancer cells by inhibiting non-homologous end joining.
Oike T; Ogiwara H; Torikai K; Nakano T; Yokota J; Kohno T
Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):815-21. PubMed ID: 22417805
[TBL] [Abstract][Full Text] [Related]
8. Anti-proliferative and anti-invasive effects of garcinol from
Duan YT; Yang XA; Fang LY; Wang JH; Liu Q
Pharmazie; 2018 Jul; 73(7):413-417. PubMed ID: 30001777
[TBL] [Abstract][Full Text] [Related]
9. Induction of p21(Waf1/Cip1) by garcinol via downregulation of p38-MAPK signaling in p53-independent H1299 lung cancer.
Yu SY; Liao CH; Chien MH; Tsai TY; Lin JK; Weng MS
J Agric Food Chem; 2014 Mar; 62(9):2085-95. PubMed ID: 24533688
[TBL] [Abstract][Full Text] [Related]
10. Differential effects of garcinol and curcumin on histone and p53 modifications in tumour cells.
Collins HM; Abdelghany MK; Messmer M; Yue B; Deeves SE; Kindle KB; Mantelingu K; Aslam A; Winkler GS; Kundu TK; Heery DM
BMC Cancer; 2013 Jan; 13():37. PubMed ID: 23356739
[TBL] [Abstract][Full Text] [Related]
11. Garcinol inhibits cancer stem cell-like phenotype via suppression of the Wnt/β-catenin/STAT3 axis signalling pathway in human non-small cell lung carcinomas.
Huang WC; Kuo KT; Adebayo BO; Wang CH; Chen YJ; Jin K; Tsai TH; Yeh CT
J Nutr Biochem; 2018 Apr; 54():140-150. PubMed ID: 29414668
[TBL] [Abstract][Full Text] [Related]
12. Garcinol inhibits tumour cell proliferation, angiogenesis, cell cycle progression and induces apoptosis via NF-κB inhibition in oral cancer.
Aggarwal S; Das SN
Tumour Biol; 2016 Jun; 37(6):7175-84. PubMed ID: 26662963
[TBL] [Abstract][Full Text] [Related]
13. Garcinol: Current status of its anti-oxidative, anti-inflammatory and anti-cancer effects.
Liu C; Ho PC; Wong FC; Sethi G; Wang LZ; Goh BC
Cancer Lett; 2015 Jun; 362(1):8-14. PubMed ID: 25796441
[TBL] [Abstract][Full Text] [Related]
14. Ex vivo expansion of human hematopoietic stem cells by garcinol, a potent inhibitor of histone acetyltransferase.
Nishino T; Wang C; Mochizuki-Kashio M; Osawa M; Nakauchi H; Iwama A
PLoS One; 2011; 6(9):e24298. PubMed ID: 21931675
[TBL] [Abstract][Full Text] [Related]
15. Garcinol Is an HDAC11 Inhibitor.
Son SI; Su D; Ho TT; Lin H
ACS Chem Biol; 2020 Nov; 15(11):2866-2871. PubMed ID: 33034447
[TBL] [Abstract][Full Text] [Related]
16. Garcinol, a multifaceted sword for the treatment of Parkinson's disease.
Deb S; Phukan BC; Mazumder MK; Dutta A; Paul R; Bhattacharya P; Sandhir R; Borah A
Neurochem Int; 2019 Sep; 128():50-57. PubMed ID: 30986504
[TBL] [Abstract][Full Text] [Related]
17. Protective effects of garcinol in mice with lipopolysaccharide/D-galactosamine-induced apoptotic liver injury.
Jing Y; Ai Q; Lin L; Dai J; Jia M; Zhou D; Che Q; Wan J; Jiang R; Zhang L
Int Immunopharmacol; 2014 Apr; 19(2):373-80. PubMed ID: 24560905
[TBL] [Abstract][Full Text] [Related]
18. Garcinol, a polyisoprenylated benzophenone modulates multiple proinflammatory signaling cascades leading to the suppression of growth and survival of head and neck carcinoma.
Li F; Shanmugam MK; Chen L; Chatterjee S; Basha J; Kumar AP; Kundu TK; Sethi G
Cancer Prev Res (Phila); 2013 Aug; 6(8):843-54. PubMed ID: 23803415
[TBL] [Abstract][Full Text] [Related]
19. Garcinol Sensitizes NSCLC Cells to Standard Therapies by Regulating EMT-Modulating miRNAs.
Farhan M; Malik A; Ullah MF; Afaq S; Faisal M; Farooqi AA; Biersack B; Schobert R; Ahmad A
Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30781783
[TBL] [Abstract][Full Text] [Related]
20. Garcinol exerts anti-cancer effect in human cervical cancer cells through upregulation of T-cadherin.
Zhao J; Yang T; Ji J; Li C; Li Z; Li L
Biomed Pharmacother; 2018 Nov; 107():957-966. PubMed ID: 30257408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
